Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1HETERO DRUGS LIMITED Hyderabad IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for CEP 2016-197 - Rev 02 of Hetero Drugs Limited Hyderabad In

Looking for Certificates of Suitability (CEPs) for CEP 2016-197 - Rev 02 of Hetero Drugs Limited Hyderabad In 1

20

Hetero Drugs Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Lisinopril dihydrate, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2016-197 - Rev 02

This Chemical Type CEP, issued on July 03, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1120 associated with this CEP further emphasizes